Thanks to breakthroughs in treatment and care, people living with cystic fibrosis (CF) have a chance at living fuller, healthier lives. Despite this progress, many existing therapies deliver only partial function to people living with #CF. That’s why we are working to develop additional treatment options that have the potential to fully restore normal #CFTR function. Learn more: https://lnkd.in/g_JNv62P
Sionna Therapeutics
Biotechnology
Boston, MA 3,435 followers
Dedicated to delivering therapies that could be transformational for people living with cystic fibrosis.
About us
We are a life sciences company that is building on over a decade of extensive research on the genetic mutations associated with cystic fibrosis. We are developing first-in-class small molecules that are focused on a unique target with the potential to fully normalize CFTR function for the first time for the vast majority of people living with CF.
- Website
-
https://www.sionnatx.com/
External link for Sionna Therapeutics
- Industry
- Biotechnology
- Company size
- 11-50 employees
- Headquarters
- Boston, MA
- Type
- Privately Held
- Founded
- 2019
- Specialties
- life sciences, biotechnology, pharmaceuticals, cystic fibrosis, protein function, genetics, genetic mutation, genetic disease, clinical research, clinical study, research, small molecule, molecular engineering, chemistry, patient advocacy, drug development, clinical development, lung, orphan disease, and rare disease
Locations
-
Primary
Boston, MA, US
Employees at Sionna Therapeutics
Updates
-
Our Director, Head of Starting Materials, Gerald Artman is well-positioned to aid in the development of our #CysticFibrosis (CF) development programs. He shares a message about what he looks forward to as he steps into his new role. Welcome to the team, Jerry!
-
Our team came together for the Cystic Fibrosis Foundation’s #GreatStrides Walk in Boston this past weekend. Thanks to everyone who participated—we're making strides towards a brighter future for those with #CysticFibrosis (CF). Great Strides is the CFF’s largest national fundraising program, with nearly 300 walks every year. The events aim to raise awareness of #CF, fund research, and support the CF community. Learn more: https://fightcf.cff.org
-
Today is #ClinicalTrialsDay, an initiative of the ACRP - Association of Clinical Research Professionals that aims to recognize the work of clinical research professionals. As a #clinical stage company with multiple projected milestones in 2024, we recognize the role professionals play in paving the way toward groundbreaking medical discoveries and shaping the future of #CysticFibrosis (CF) treatment and care. Learn more: https://lnkd.in/e9r9k5Wu #CTD2024
-
Our team's commitment to Intentional Innovation drives us to push boundaries and set higher standards of care for people living with #CysticFibrosis (CF). Learn more about our core values: https://lnkd.in/etdzEAVY
-
Managing cystic fibrosis presents unique challenges that may have an impact on one’s mental well-being. As we recognize both #CFAwarenessMonth and #MentalHealthMonth, we are pleased to highlight the importance of #mentalhealth awareness for people living with cystic fibrosis (CF). Learn more via the Cystic Fibrosis Foundation: https://lnkd.in/eiwTSvCh
-
During #CFAwarenessMonth, we're proud to amplify the voice of Jerry Cahill, an inspiring advocate who lives with cystic fibrosis (#CF). As we work towards improved outcomes for all people living with CF, Jerry's passion and commitment serve as a reminder that living with CF doesn't define one's spirit– it fuels the determination to make a difference. Thanks for sharing, Jerry! #CFAdvocate
-
In honor of #CFAwarenessMonth, our team hosted a bake sale to raise money for the Boomer Esiason Foundation’s scholarship program, which has awarded over $3,750,000 in academic scholarships to students in the cystic fibrosis (#CF) community who are pursuing higher education. Thanks to everyone who baked, bought, and contributed to making a difference! Learn more: https://www.esiason.org/ #TeamBoomer
-
Our President & CEO, Michael Cloonan, shares a message about our approach to targeting the NBD1 domain of the #CFTR protein in LifeSciVC’s recent "From The Trenches" blog organized by Bruce Booth of Atlas Venture. Read the full blog here: https://lnkd.in/es4mmfCz #CFAwarenessMonth
-
In honor of #CFAwarenessMonth, we are joining Emily's Entourage to highlight their campaign, "Cross Out CF,” which aims to share perspectives and experiences of individuals affected by cystic fibrosis (#CF). As we work to improve health outcomes in CF, we commend Emily’s Entourage for their dedication to advocating for the CF community. Learn more: https://lnkd.in/gf-6v69X #CrossOutCF